IDH305( IDH-305 | IDH 305 )

Catalog No. M12434 CAS No. 1628805-46-8

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Group Booking Get Quotation Bulk Inquiry Add to Cart

Product Name

IDH305
Note

Research use only, not for human use.
Brief Description

IDH 305 (IDH305)?is a potent, selective, brain penetrant mutant IDH1 inhibitor with IC50 of 18 and 28 nM for IDH1 R132H and R132C.
Description

IDH 305 (IDH305)?is a potent, selective, brain penetrant mutant IDH1 inhibitor with IC50 of 18 and 28 nM for IDH1 R132H and R132C; exhibits >200 fold selectivity over WT IDH1 (IC50=6.14 uM), and no activtiy against IDH2 mutants; inhibits EGF-independent proliferation of HCT116-IDH1R132H+/- cells with IC50 of 20 nM; exhibits in vivo correlation of 2-HG reduction and efficacy in IDH1 mutant xenograft tumor model.Brain Cancer Phase 1 Clinical.
In Vitro

——
In Vivo

Animal Model:nu/nu mice (HMEX2838-IDH1R132C+/-PDX model)Dosage:30, 100, 300 mg/kg Administration:Oral gavage; twice daily for 21 days Result:Resulted in 62-67% 2-HG reduction and significant anti-tumor activity at 100 mg/kg and 97-99% 2-HG reduction and partial tumor regression of 32% at 300 mg/kg.
Synonyms

IDH-305 | IDH 305
Pathway

Cancer
Target

Brain Cancer
Recptor

IDH
Research Area

Cancer
Indication

Brain Cancer

CAS Number

1628805-46-8
Formula Weight

490.463
Molecular Formula

C23H22F4N6O2
Purity

>98% (HPLC)
Solubility

DMSO : ≥ 150 mg/mL 305.84 mM
SMILES

O=C1OC[C@H]([C@@H](F)C)N1C2=NC(N[C@H](C3=CC(C)=C(C4=CC(C(F)(F)F)=NC=C4)C=N3)C)=NC=C2
Chemical Name

(R)-4-((S)-1-fluoroethyl)-3-(2-(((S)-1-(4-methyl-2'-(trifluoromethyl)-[3,4'-bipyridin]-6-yl)ethyl)amino)pyrimidin-4-yl)oxazolidin-2-one

1. Cho YS, et al. ACS Med Chem Lett. 2017 Sep 18;8(10):1116-1121.

Calculator

molnova catalog